Bulls, Bears: Sepsis and Anti-Infectives in the Public Markets

The threat of infection in hospital and other treatment facilities have dramatically increased over the last few years. Antibiotics and other therapies have become impotent against certain pathogens and infections, increasing the need for research funding for creating new antibiotics. These three companies have the potential to solve a significant unmet medical need.

Read more »

PLC Medical Systems Uses Revenue in the EU to Fund Phase III Development in the US

Mark Tauscher, President and CEO of PLC Medical Systems Inc., discusses the company’s product RenalGuard, an important tool for ridding the body of toxins.

Read more »